Parkinsn's Email List Message
Posting to the Parkinsn List is a benefit of Subscription
Re: Eldepryl Mortality Rate
>This is a fairly heavy duty charge. I think someone on this net who is
>qualfied ought to get to the bottom of this announcement. What are the
>studies that have been done? What are the results? Why are doctors
>prescribing eldpryl?
Firstly:
- I'm not qualified
- I don't know the details of the study
- So this is just my point of view!
I think you might find that in the end patients have a choice along the
lines of:
- either on't take eldpryl and have a possibly slightly longer life
- or take eldpryl and perhaps have a better quality of life with
perhaps a slightly reduced life expectancy
i.e. patients are going to have a *choice* which they can discuss with
their medical advisor and make the best decision for them.
Having said that, I don't think the experts have agreed much yet.
Simon
--------- My opinions are my own, NIP's opinions are theirs ----------
Simon J. Coles Email: simon@xxxxxxxxxx
New Information Paradigms Work Phone: +44 1344 778783
Work Fax: +44 1344 772510
=============== Life is too precious to take seriously ===============
Parkinsn's Archive Treasures Doctors, students, patients and caregivers find current Parkinson's information such as the Algorithm, Caregivers Handbook, and talks by respected Movement Disorder Specialists.
Mail converted by MHonArc
2.6.10
Site Hosting donated by He.net
&
Grant from The Parkinson Alliance